Ventures Lundbeckfonden Ventures 7. april 2021 PsiOxus Therapeutics Updates Agreement with Bristol Myers Squibb to Advance their Clinical Stage Immuno-Oncology Collaboration Lundbeckfonden Ventures 16. december 2020 PsiOxus Therapeutics Announce Executive Team Reorganization with Two New C Level Appointments in the US Lundbeckfonden Ventures 16. december 2020 Atox Bio Closes $30 Million Investment Lundbeckfonden Ventures 16. december 2020 Atox Bio Closes $30 Million Investment Tiburio 14. december 2020 Lundbeck Foundation invests in treatment for rare tumours Lundbeckfonden Ventures 14. december 2020 Lundbeckfonden investerer i middel mod sjældne tumorer Amplyx 10. december 2020 Amplyx Announces Presentations on Fosmanogepix (APX001) at IDWeek 2019 and the 9th Congress on Trends in Medical Mycology (TIMM-9) Atox Bio 9. december 2020 Atox Bio Announces a Positive Effect of Reltecimod on Resolution of Organ Dysfunction in Phase 3 ACCUTE Trial for Patients with Necrotizing Soft Tissue Infection (“Flesh Eating Disease”) Sanifit 11. november 2020 Subgroup Analyses from Sanifit’s CaLIPSO Phase 2b Clinical Study Published in Kidney International Reports Acacia Pharma 9. oktober 2020 Acacia Pharma Group PLC – Acacia Pharma completes drawdown from €25 million loan facility from Cosmo Pharmaceuticals to support US launches of BARHEMSYS® and BYFAVO™ Sideinddeling Nuværende side 1 Side 2 Side 3 Side 4 Side 5 Side 6 Side 7 Side 8 Side 9 … Næste side ›› Sidste side Sidste »
